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The South African National Health Act (No. 61 of 2003) provides a legal framework for the regulation of the health system across 
the country. Within the Act, section 71 introduces a number of legal norms relating to research or experimentation with human 
subjects, including research on HIV prevention and treatment. These norms have been criticised for the negative impact they 
will have on research involving children. This article describes three of the new consent requirements in section 71 of the Act. It 
shows, using a range of case studies, how important HIV-related research will be halted or undermined if the current provisions 
are implemented. The article argues that the new consent requirements are out of step with other statutory provisions and 
ethical guidelines, and as a result they will exclude a large population group – children in diverse settings – from much-needed 
evidence-based healthcare interventions. The article concludes with a clarion call for support of advocacy on this issue with the 
Minister of Health and the Health Portfolio Committee. 
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Section 71 of the South African (SA) National 
Health Act (NHA),[1] which deals with research 
on or experimentation with human subjects, 
was put into operation on 1 March 2012.[2] This 
section fundamentally changes the way in which 
research with children may be undertaken across the country 
by introducing highly restrictive and inflexible standards into 
the current SA ethical-legal framework.[3,4] As a result, it has 
come under heavy criticism for limiting important research 
with children and containing impractical and unrealisable 
provisions.[3-9]
The full impact of section 71 has yet to be felt, as very few 
research ethics committees (RECs) require researchers to comply 
with its standards. However, this grace period may be coming to 
an end; on 29 May 2013, draft Regulations Relating to Research on 
Human Subjects[10] were published for public comment, indicating 
that the full implementation of section 71 is imminent.  
This article focuses on three aspects of section 71, which we 
believe will have far-reaching consequences for research on 
children. It shows, using a range of case studies, how important 
research will be halted or undermined if the current provisions 
are implemented. The article concludes with a call to support 
advocacy in law reform.
The importance of health 
research with children
There is a global trend towards greater inclusivity in research 
practices and to facilitate research with children, while recog-
nising that they need to be protected.[12] This approach flows 
from a recognition of the following: 
• The number and severity of diseases that affect children 
is growing: for example, 17% of all 15 - 49-year-olds are 
HIV-positive.[13] Furthermore, mortality among children is 
unacceptably high, with one out of every ten deaths in the 
entire population being a child under the age of 14.[14]
• Some disorders occur only in children or are more common 
in children; for example, type 1 diabetes[15] and juvenile 
rheumatoid arthritis.[16,17]
A note on terminology: This article uses the term ‘children’ to refer to persons under the age of 18.[11] However, the NHA uses 
the term ‘minors’ in section 71; therefore, when we refer directly to this section we use ‘minors’ rather than children. We also 
limit our discussion to ‘health research’ on a ‘living person’, as the regulations in section 71 only apply to these types of studies. 





• The dynamics in some diseases are different in children compared 
with adults. For example, 20% of untreated HIV-infected infants will 
die within 90 days of birth,[18] 40% within their first year of life, and 
52% by the end of their second year.[19] This type of rapid mortality 
does not occur among newly infected adults.
• Certain medication has a different impact on children as opposed 
to adults, as they have differing biokinetics, metabolism, physiology 
and immunology, and metabolise medicines differently. This results 
in children needing different dosages, which can only be established 
through research.[20] Without research, limited information is avail-
able on the efficacy and safety of many of the medicines commonly 
used in children.[20] 
• There is a developing trend against allowing the licensing of drugs, 
vaccines and other interventions for children before testing their 
safety and efficacy in this age group. There is also concern about the 
‘off label’ use of medicines in children.[20] 
• Using the results from clinical trials on children has resulted 
in significant health benefits for them.[21] For example, human 
papilloma virus (HPV) vaccine studies on children have enabled 
them to receive the vaccine, which can prevent cervical cancer and 
genital warts.[22] 
• Laws such as the Children’s Act emphasise that children have the right 
to participate in decision making.[11] Likewise, ‘their participation in 
research is akin to respecting and promoting their entitlement to 
have their opinions heard. It assumes that they are persons of value, 
their experiences are of interest to themselves, and to others, and that 
they have a valuable contribution to make.’[23] 
Against this backdrop, it is argued that an approach that excludes 
children from health research, including research related to HIV 
prevention and treatment, infringes on their constitutional rights to 
both ‘basic health care’ and access to ‘healthcare services’.[24] For example, 
their exclusion results in ineffective and even harmful interventions 
being used owing to the lack of evidence on drug efficacy or dosage.[21] 
This also has unintended consequences, such as research being delayed 
or risking lack of funding due to extended enrolment periods that may 
be required in order to comply with a restrictive legal framework. This 
may result in research being undertaken in other countries, where the 
ethical-legal framework is more flexible.
New restrictive regulations for 
all forms of health research with 
human subjects
New standards on health research with children have been introduced, 
which will limit the circumstances in which they may participate 
in research. Three of the new consent regulations in section 71 are 
described and critiqued below.
Requiring written consent 
Section 71 of the NHA provides that research participants must give 
written, informed consent to health research.[1] This will have serious 
implications for certain types of health research, such as telephonic 
interviews and postal or electronic studies, in which the voluntary 
completion of a questionnaire is commonly regarded as consent.[25] It 
also excludes the use of passive consent (informing parents of a study 
and assuming they have agreed to their child participating, unless 
otherwise instructed) – a practice frequently used with adolescent 
school-based studies.[9]
This approach is out of step with the more flexible approach in the 
National Health Research Ethics Council (NHREC) guidelines, which 
provide that consent may be given verbally or in writing. Consent may 
also, in certain circumstances, be waived, if prior approval of the REC 
is obtained.[26] 
Prohibiting independent consent  
from minors
The NHA[1] provides in section 71 that consent must be obtained from 
parents or legal guardians, and minors if they have understanding. In 
other words, children under the age of 18 do not have the capacity to 
consent independently to any form of health research, but they may 
in certain circumstances provide dual consent alongside that of their 
parents or guardians. 
Mandatory parental consent means that it will no longer be possible 
to undertake health research where it involves the following:
• Certain socially marginalised groups. For example, adolescent men 
who have sex with men are highly stigmatised in SA, and may 
face social harms if they are required to seek parental consent to 
participate in research focusing on their sexuality or sexual practices. 
• Behaviour that is legal, but which may incur parental disapproval or 
reprisal. An example is termination of pregnancy in young girls, as 
it is likely that very few teenage girls would be willing to approach 
their parents for consent to a study on a decision they had made 
autonomously to terminate a pregnancy. Even though this is a 
lawful decision, studies have confirmed that teenagers will not use 
such services if they have to obtain parental consent for fear of 
disapproval.[27] 
• Illegal behaviours. For example, studies into illegal practices such 
as child drug use or child prostitution would be complicated by 
concerns that: (i) children would not be prepared to seek parental 
consent, or (ii) parents are in fact not available to provide such 
consent. 
• Minimal or no-risk research with children over the age of 12, 
using a passive consent approach.[9] For example, this could include 
completing surveys about drug, alcohol or sexual abuse, eating 
disorders, attitudes towards oral hygiene, exercise behaviour or even 
experiences of healthcare provision.
• Orphaned and vulnerable children (OVCs) who do not have parents 
or legal guardians who are able to consent. This is discussed further 
below.
It is worth noting that in all of the above examples, the children are 
likely to be considerably more vulnerable and at risk of ill health than 
their peers, and research and consequent evidence-based intervention 
with these groups is particularly pertinent (Table 1).
Prohibiting independent consent from minors is also problematic, 
in that it conflicts with the consent provisions in the Children’s Act,[11] 
which recognises the evolving capacity of children, and allows them 
to consent to a range of health interventions before the age of 18.[31] 
Furthermore, this regulation in the NHA is diametrically opposed to 
those in the NHREC ethical guidelines, which, for example, allow for 
independent consent by children in certain circumstances.[26] 
Limiting the authority to provide proxy 
consent to parents or legal guardians
Section 71 of the NHA limits the authority to provide proxy consent to 
either parents or legal guardians. Generally, parents are the biological 





or adoptive parents of a child, while a guardian is a ‘person with 
guardianship of a child’.[11] Unmarried, biological mothers over the 
age of 18 are automatically the guardian of their child, and in certain 
circumstances an unmarried father will be a co-guardian. If the 
biological parents are married, they will be joint guardians. A guardian 
may also be appointed by the High Court or nominated by a parent 
in a will.[11] Persons caring for children but not falling into any of the 
categories above will, in the future, not be able to provide consent for 
children to participate in health research. This will affect a significant 
number of children, given that it is estimated that by 2015, ~5 700 000 
children would have lost one or both parents to AIDS.[32]
In essence, this means that future studies with children who do not 
have parents or legal guardians will no longer be possible. Furthermore, 
such children may not volunteer for health research, as they do not 
have an adult with the legal authority to provide proxy consent. This 
principle will also apply to mothers under the age of 18 who have lost 
parental support but who are at particular risk of both HIV acquisition 
and transmission. There are also far-reaching implications for research 
on child-headed households, OVCs and undocumented migrant 
children. OVCs are increasingly recognised as a special population in 
terms of HIV risk and transmission, yet they will not be able to inform 
research.[33] OVC and child-headed households present unique and 
contemporary issues that must be responded to. 
Limiting the authority to provide proxy consent to parents and legal 
guardians is also out of step with the Children’s Act, which recognises 
that caregivers may consent to certain health interventions such as 
medical treatment and HIV testing on behalf of children.[34]
Conclusions
Given the principled nature of many of the concerns set out above, we 
call on the Minister of Health and the Parliamentary Health Portfolio 
Committee to address the need for law reform as a matter of urgency. If 
research institutions are required to comply with these regulations, child 
research in SA will grind to a halt, and this will ultimately harm the 
population it purports to protect. Ensuring and supporting rigorous and 
equitable review by RECs, and promoting clear communication to children 
and their caregivers during consent and study processes, should be the 
emphasis of developments in this field rather than restrictive legislation 
that reduces access to research participation. The nature and form of 
consent should be driven by the research itself, its benefits, risks, costs and 
consequences, rather than a blanket one-size-fits-all approach.[25] 
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